Tissue transglutaminase is increased in Huntington's disease brain.
The polyglutamine-expanded N-terminal region of mutant huntingtin causes neurodegeneration in Huntington's disease (HD). Neuronal intranuclear and cytosolic inclusions composed of mutant huntingtin are found in brains of HD patients. Because tissue transglutaminase cross-links proteins into filamentous aggregates and polypeptide-bound glutamines are primary determining factors for tissue transglutaminase-catalyzed reactions, it has been hypothesized that tissue transglutaminase may contribute to the formation of these aggregates. In this report immunohistochemical and biochemical methods were used to demonstrate that tissue transglutaminase expression and transglutaminase activity are elevated in HD brains in a grade-dependent manner. In the striatum, tissue transglutaminase activity was significantly increased in the grade 3 HD cases compared with controls. When normalized to the neuronal marker calbindin D28k, immunoblot analysis revealed that in the striatum the levels of tissue transglutaminase were significantly increased in all HD cases compared with controls. Immunohistochemical staining of the HD striatum revealed that tissue transglutaminase immunoreactivity was markedly increased in all grades as compared with controls. In the superior frontal cortex, tissue transglutaminase activity was significantly higher in all HD cases as compared with controls. Quantitative analysis of immunoblots demonstrated that tissue transglutaminase levels were elevated in HD grades 2 and 3 cases. Tissue transglutaminase immunoreactivity within the superior frontal neocortex was also greater in all the HD cases compared with controls. These data clearly indicate that tissue transglutaminase is elevated in HD brain and may play a role in the disease process.
Lesort
M
M
Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, 35294-0017, USA.
Chun
W
W
Johnson
G V
GV
Ferrante
R J
RJ
D000368:Aged; D001921:Brain / Q000201:enzymology*; D064092:Calbindin 1; D064026:Calbindins; D002467:Cell Nucleus / Q000201:enzymology; D002531:Cerebellum / Q000201:enzymology; D003342:Corpus Striatum / Q000201:enzymology; D003593:Cytoplasm / Q000201:enzymology; D005625:Frontal Lobe / Q000201:enzymology; D006801:Humans; D006816:Huntington Disease / Q000201:enzymology*; D015151:Immunoblotting; D007150:Immunohistochemistry; D019579:Neocortex / Q000201:enzymology; D009474:Neurons / Q000737:chemistry; D064030:S100 Calcium Binding Protein G / Q000032:analysis; D011503:Transglutaminases / Q000378:metabolism*
C576498:CALB1 protein, human; D064092:Calbindin 1; D064026:Calbindins; D064030:S100 Calcium Binding Protein G; D011503:Transglutaminases